Scholarly Index
Matthew I. Milowsky
UNC Lineberger Comprehensive Cancer Center; 17,968 total citations; 412 total publications; best world rank #23
UNC Lineberger Comprehensive Cancer Center
17,968Total citations
412Total publications
67H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Bladder and Urothelial Cancer Treatments | Lifetime | 101 | — | 99.45 |
| Urinary and Genital Oncology Studies | Lifetime | 60 | — | 99.45 |
| Renal cell carcinoma treatment | Lifetime | 303 | — | 98.55 |
| Cancer Immunotherapy and Biomarkers | Lifetime | 735 | — | 98.43 |
| Multiple and Secondary Primary Cancers | Lifetime | 256 | — | 97.33 |
| Prostate Cancer Treatment and Research | Lifetime | 910 | — | 97.56 |
| Radiopharmaceutical Chemistry and Applications | Lifetime | 837 | — | 96.38 |
| Fibroblast Growth Factor Research | Lifetime | 787 | — | 91.33 |
| Infectious Disease Case Reports and Treatments | Lifetime | 681 | — | 68.08 |
| Bladder and Urothelial Cancer Treatments | 2021-2025 | 34 | — | 99.45 |
| Urinary and Genital Oncology Studies | 2021-2025 | 23 | — | 99.39 |
| Cancer Immunotherapy and Biomarkers | 2021-2025 | 351 | — | 98.65 |
| Cancer Research and Treatments | 2021-2025 | 534 | — | 83.99 |
| Multiple and Secondary Primary Cancers | 2021-2025 | 374 | — | 80.33 |
| Fibroblast Growth Factor Research | 2021-2025 | 453 | — | 70.12 |